Saudi Arabia Phenylketonuria Market Size & Outlook, 2026-2034

Saudi Arabia Phenylketonuria Market Insights

As highlighted in Reed Intelligence analysis, the Saudi Arabia Phenylketonuria Market, worth USD 18.39 Million in 2025, is forecasted to achieve USD 32.72 Million by 2034.
The Saudi Arabia market is anticipated to grow at a CAGR of 6.51% during the period 2026–2034.
By 2025, Enzyme Replacement Therapy represented the largest share of the By Treatment Type market size.
Enzyme Replacement Therapy is expected to remain the key growth driver within By Treatment Type, registering the fastest CAGR during the forecast period.

Other Key Findings

As of 2025, Saudi Arabia held 1.39% of the global Phenylketonuria Market size.
By 2034, United States is anticipated to capture the largest share of the global Phenylketonuria Market.
In Middle East and Africa, United Arab Emirates is expected to lead the regional Phenylketonuria Market size by 2034.
Egypt will remain the fastest-growing market in Middle East and Africa, reaching USD 15.86 Million by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 18.39 Million
Market Size In 2034	USD 32.72 Million
Largest segment	Enzyme Replacement Therapy
Units	Revenue in USD Million
CAGR	6.51% (2026-2034)
Segmnetation Covered
By Treatment Type	Enzyme Replacement Therapy Gene Therapy Medication Dietary Therapy
By Diagnosis	Genetic Testing Biochemical Testing Newborn Screening
By End-User	Specialty Clinics Research Institutes Home Healthcare Hospitals
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Saudi Arabia Phenylketonuria Market By Treatment Type 2026-2034 (USD Million)

By Treatment Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Enzyme Replacement Therapy	XX.x	XX.x	XX.x	8.27	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Gene Therapy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Medication	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Dietary Therapy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Saudi Arabia Phenylketonuria Market By Diagnosis 2026-2034 (USD Million)

By Diagnosis	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Genetic Testing	XX.x	XX.x	XX.x	8.46	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Biochemical Testing	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Newborn Screening	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Saudi Arabia Phenylketonuria Market By End-User 2026-2034 (USD Million)

By End-User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Specialty Clinics	XX.x	XX.x	XX.x	8.77	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research Institutes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Home Healthcare	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Hospitals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.